61. THU0146 Impact of anti-Drug Antibodies on Efficacy and Safety Up To Week 24 from A Phase III Study Comparing SB5 (An Adalimumab Biosimilar) with Adalimumab Reference Product in Patients with Moderate To Severe Rheumatoid Arthritis despite Methotrexate Therapy. (15th July 2016) Authors: Genovese, M.C.; Weinblatt, M.; Keystone, E.; Baranauskaite, A.; Cheong, S.Y.; Ghil, J. Journal: Annals of the rheumatic diseases Issue: Volume 75(2016)Supplement 2 Page Start: 234 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
62. THU0156 Impact of Golimumab on Physical Function and Employability of Patients with Rheumatoid Arthritis: 5-Year Data from 3 Phase III Clinical Trials. (10th June 2014) Authors: Han, C.; Keystone, E.; Fleischmann, R.; Smolen, J.; Matteson, E.L.; Emery, P.; Genovese, M.; Gathany, T.; Hsia, E.C. Journal: Annals of the rheumatic diseases Issue: Volume 73:Supplement 2(2014) Page Start: 234 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
63. THU0162 Multiple Approaches for Implementation of Long-Term Efficacy Interpretation of Certolizumab Pegol Data: RAPID1 and RAPID2 CASE Study. (10th June 2014) Authors: Keystone, E.; Smolen, J.S.; Strand, V.; Kumke, T.; Walker, S.; Mountian, I.; Landewé, R. Journal: Annals of the rheumatic diseases Issue: Volume 73:Supplement 2(2014) Page Start: 236 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
64. THU0169 Persistence of Tofacitinib in The Treatment of Rheumatoid Arthritis in Open-Label, Long-Term Extension Studies up To 7 Years. (15th July 2016) Authors: Pope, J.; Keystone, E.; Jamal, S.; Wang, L.; Fallon, L.; Woolcott, J.; Lazariciu, I.; Haraoui, B. Journal: Annals of the rheumatic diseases Issue: Volume 75(2016)Supplement 2 Page Start: 245 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
65. THU0173 Achievement and Maintenance of Remission/Low Disease Activity over 24 Months in Patients with Rheumatoid Arthritis Treated with Etanercept or Etanercept + Methotrexate in the Canadian Methotrexate and Etanercept Outcome (CAMEO) Study. (10th June 2014) Authors: Pope, J.E.; Haraoui, B.; Thorne, J.C.; Phan-Chronis, K.; Poulin-Costello, M.; Vieira, A.; Keystone, E. Journal: Annals of the rheumatic diseases Issue: Volume 73:Supplement 2(2014) Page Start: 240 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
66. THU0175 Effects of Baricitinib on Multibiomarker Disease Activity Scores and Their Components in a Phase 2B Study in Moderate-to-Severe Rheumatoid Arthritis Patients. (9th June 2015) Authors: Taylor, P.; Genovese, M.C.; Keystone, E.; Weinblatt, M.; Rancourt, J.; Nantz, E.; Schlichting, D.; Zuckerman, S.; Macias, W. Journal: Annals of the rheumatic diseases Issue: Volume 74(2015)Supplement 2 Page Start: 257 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
67. THU0176 Golimumab 5-Year Safety: an Analysis of Pooled Data from the Long Term Extensions of Randomized, Double-Blind, Placebo-Controlled Studies in Rheumatoid Arthritis, Psoriatic Arthritis, and Ankylosing Spondylitis. (10th June 2014) Authors: Kay, J.; Fleischmann, R.; Keystone, E.; Hsia, E.C.; Goldstein, N.; Hsu, B.; Zhou, Y.; Braun, J.; Kavanaugh, A. Journal: Annals of the rheumatic diseases Issue: Volume 73:Supplement 2(2014) Page Start: 241 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
68. THU0180 Lack of Early Change in Disease Activity Score Predicts The Likelihood of Achieving Low Disease Activity at Month 6: Tofacitinib Monotherapy versus Methotrexate in Methotrexate-Naïve Patients with Rheumatoid Arthritis. (15th July 2016) Authors: Keystone, E.; van Vollenhoven, R.F.; Wilkinson, B.; Fallon, L.; Hwang, L.-J.; Chapman, D.; DeMasi, R.; Lee, E.B. Journal: Annals of the rheumatic diseases Issue: Volume 75(2016)Supplement 2 Page Start: 250 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
69. THU0184 Impact of immunogenicity on clinical efficacy and administration related reaction in tnf inhibitors: a pooled-analysis from three biosimilar studies in patients with rheumatoid arthritis. (12th June 2018) Authors: Emery, P.; Weinblatt, M.; Smolen, J.S.; Keystone, E.; Genovese, M.; Vencovsky, J.; Kay, J.; Hong, E.; Baek, Y.; Ghil, J. Journal: Annals of the rheumatic diseases Issue: Volume 77(2018)Supplement 2 Page Start: 310 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
70. THU0186 Does Early Steroid Use Increase The Likelihood of Achieving Remission at 6 Months in Early RA? Results from The Canadian Early Arthritis Cohort. (15th July 2016) Authors: Andersen, K.M.; Bartlett, S.J.; Lin, D.; Schieir, O.; Boire, G.; Haraoui, B.; Hitchon, C.; Jamal, S.; Keystone, E.; Pope, J.; Tin, D.; Thorne, C.; Bykerk, V.P. Journal: Annals of the rheumatic diseases Issue: Volume 75(2016)Supplement 2 Page Start: 252 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗